Suresh G Shelat
Overview
Explore the profile of Suresh G Shelat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubo K, Hori M, Ohta K, Handa H, Hatake K, Matsumoto M, et al.
Int J Hematol
. 2019 Nov;
111(1):65-74.
PMID: 31701481
Novel therapies are needed for patients with newly diagnosed multiple myeloma (NDMM). Elotuzumab plus lenalidomide and dexamethasone (ELd) is approved for the treatment of relapsed/refractory multiple myeloma (RRMM). This phase...
2.
Dimopoulos M, Dytfeld D, Grosicki S, Moreau P, Takezako N, Hori M, et al.
N Engl J Med
. 2018 Nov;
379(19):1811-1822.
PMID: 30403938
Background: The immunostimulatory monoclonal antibody elotuzumab plus lenalidomide and dexamethasone has been shown to be effective in patients with relapsed or refractory multiple myeloma. The immunomodulatory agent pomalidomide plus dexamethasone...
3.
Kashyap M, Kumar D, Jones H, Amaya-Chanaga C, Choi M, Melo-Cardenas J, et al.
Oncotarget
. 2015 Dec;
7(3):2809-22.
PMID: 26646452
The CXCR4 receptor (Chemokine C-X-C motif receptor 4) is highly expressed in different hematological malignancies including chronic lymphocytic leukemia (CLL). The CXCR4 ligand (CXCL12) stimulates CXCR4 promoting cell survival and...
4.
Kinder M, Thompson J, Wei C, Shelat S, Blair I, Carroll M, et al.
Exp Hematol
. 2010 Jul;
38(11):1036-1046.e1-4.
PMID: 20647030
Objective: Several transcription factors determine the cell fate decision between granulocytes and monocytes, but the upstream signal transduction pathways that govern myelopoiesis are largely unknown. Based on our observation of...
5.
Shelat S
Am J Med
. 2010 Jun;
123(9):777-84.
PMID: 20541168
The general medicine and critical care services often care for patients that require therapeutic apheresis. Apheresis procedures are performed for various hematologic, neurological, renal, autoimmune, metabolic, and other indications. To...
6.
Kinder M, Wei C, Shelat S, Kundu M, Zhao L, Blair I, et al.
Blood
. 2010 Apr;
115(24):5012-22.
PMID: 20357242
Fatty acid metabolism governs multiple intracellular signaling pathways in many cell types, but its role in hematopoietic stem cells (HSCs) is largely unknown. Herein, we establish a critical role for...
7.
Shelat S, Lott J, Braga M
Transfusion
. 2009 Dec;
50(4):875-80.
PMID: 20003050
Background: Travelers returning to the United States from malaria-endemic areas are at increased risk of a potentially fatal infection from Plasmodium falciparum, which requires prompt and aggressive treatment. Study Design...
8.
Chen M, Logan T, Hochberg M, Shelat S, Yu X, Wilding G, et al.
Blood
. 2009 Sep;
114(19):4045-53.
PMID: 19734452
Recent reports describe hematopoietic abnormalities in mice with targeted instability of the mitochondrial genome. However, these abnormalities have not been fully described. We demonstrate that mutant animals develop an age-dependent,...
9.
Farrell S, Shelat S, Kim H, Drew C
Transfusion
. 2009 Feb;
49(6):1255-8.
PMID: 19222819
Background: In automated erythrocytapheresis procedures, achieving the desired-end hematocrit (Hct) requires that the COBE Spectra (CaridianBCT) machine be programmed with the mean Hct of the replacement red blood cell (RBC)...
10.
Shelat S
Clin Appl Thromb Hemost
. 2008 Oct;
16(2):224-7.
PMID: 18840631
Described is a case of acute chest syndrome in a sickle-cell patient (hemoglobin SS) who also developed signs and symptoms of thrombotic thrombocytopenic purpura, including thrombocytopenia and hemolysis (anemia, elevated...